Sonoma Pharmaceuticals, Inc. — Director's Dealing 2007

Jan 24, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2007-01-24

Reporting Person: Wokasch Michael (Chief Operating Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$12.00	2016-07-27	Common Stock (124999)		Direct

Footnotes

F1: The option becomes exercisable as to 20% of the shares on June 9, 2007, and becomes exercisable as to 1/60th of the remaining shares each full month thereafter.